Last reviewed · How we verify
NCT04335747
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases
trial testing COVID-19 infection in Rheumatoid Arthritis in 53 participants. Terminated before completion.
1 July 2021
Quick facts
| Lead sponsor | Salome Kristensen |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 53 |
| Start date | 23 April 2020 |
| Primary completion | 1 July 2021 |
| Estimated completion | 1 July 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- COVID-19 infection
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Psoriatic Arthritis — all drugs for Psoriatic Arthritis →
- Axial Spondyloarthritis — all drugs for Axial Spondyloarthritis →
- Systemic Lupus Erythematosus — all drugs for Systemic Lupus Erythematosus →
Sponsor
Salome Kristensen
Who can join
18 and older, any sex, with Rheumatoid Arthritis or Psoriatic Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The trial is a prospective, observational study aiming to identify risk factors for serious COVID-19 infection by evaluating clinical measures and biomarkers of inflammation in patients with inflammatory rheumatic disease hospitalized with COVID-19 compared with control groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04335747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of COVID-19 infection
Trials testing the same drug.
- NCT05133648 — Anesthesia Technique in COVID-19 Positive Hip Fracture Patients · unknown
- NCT05379621 — Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19 · completed
- NCT04782427 — COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave · completed
- NCT06806696 — SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA · completed
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Salome Kristensen trials
Trials by the same sponsor.
- NCT06011512 — Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica. · recruiting
- NCT04411407 — PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE · NA · completed
- NCT03486613 — PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04335747 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salome Kristensen
- Last refreshed: 21 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing